Experience of Using Sonirid Duo in the Treatment of Patients with BPH

    December 2013 in “ Urology reports (St - Petersburg)
    В Н Ткачук, Adel S. Al-Shukri, Ilya Nikolayevich Tkachuk
    TLDR Sonirid Duo effectively treats benign prostatic hyperplasia.
    The study evaluated the efficacy of Sonirid Duo, a combination of tamsulosin and finasteride, in treating 46 patients with benign prostatic hyperplasia (BPH) over 12 months. The results indicated significant improvements: the severity of clinical symptoms decreased from 18.7 to 7.8 on the IPSS scale, quality of life improved from 4.4 to 2.0 on the QoL scale, maximum urinary flow rate increased from 8.3 ml/s to 12.9 ml/s, and prostate volume reduced from 75.1 cm³ to 56.2 cm³. The study concluded that Sonirid Duo was a highly effective treatment for BPH.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    3 / 3 results